Senrebotase

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameSenrebotase
Drug Alias NameSXN 100323AGN-214868TEM
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionSoluble NSF attachment protein receptor antagonists
TargetsSoluble NSF attachment protein receptor
Therapy Area/IndicationsUrinary Bladder, OveractiveNeuralgia, Postherpetic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesPoland +[7] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHealth Protection Agency Porton Down
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan Plc
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, OveractiveNeuralgia, Postherpetic

Other Information

ATC CodeN/A
Related LinksN/A